A Biosynthetic Gene Cluster for the Acetyl-CoA Carboxylase Inhibitor Andrimid
- 1 August 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 128 (33) , 10660-10661
- https://doi.org/10.1021/ja063194c
Abstract
Increasing bacterial resistance to antibiotics with conventional targets has focused attention on antibiotics with unconventional targets. One promising candidate, the acetyl-CoA carboxylase (ACC) inhibitor andrimid, is a potent, broad-spectrum antibiotic with high selectivity for prokaryotic ACC. Here, we report the use of a DNA-based approach to clone the andrimid biosynthetic gene cluster from Pantoea agglomerans, yielding a cosmid that confers robust andrimid production on Escherichia coli. This gene cluster encodes a hybrid nonribosomal peptide/polyketide (NRP/PK) synthase with several unusual features, including three enzymes that form and insert β-phenylalanine, two transglutaminase-like enzymes that likely serve as condensation catalysts, and four densely hybrid modules that form the succinimide precursor. Unlike most type I NRPSs and PKSs, the andrimid gene cluster is a dissociated system comprised of small proteins. Therefore, future efforts can exploit the genetic manipulability of E. coli to engineer the andrimid synthase with the goal of producing a diverse set of andrimid analogues for clinical evaluation.Keywords
This publication has 27 references indexed in Scilit:
- Assembly-Line Enzymology for Polyketide and Nonribosomal Peptide Antibiotics: Logic, Machinery, and MechanismsChemical Reviews, 2006
- Cloning and Heterologous Expression of Isocyanide Biosynthetic Genes from Environmental DNAAngewandte Chemie International Edition in English, 2005
- Identification and Characterization of the First Class of Potent Bacterial Acetyl-CoA Carboxylase Inhibitors with Antibacterial ActivityJournal of Biological Chemistry, 2004
- Acute otitis media in infants younger than two months of age: microbiology, clinical presentation and therapeutic approachThe Pediatric Infectious Disease Journal, 2002
- Identification of febrile neonates unlikely to have bacterial infectionsThe Pediatric Infectious Disease Journal, 1997
- Application of criteria identifying febrile outpatient neonates at low risk for bacterial infectionsThe Pediatric Infectious Disease Journal, 1994
- Andrimid and moiramides A-C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas fluorescens: structure elucidation and biosynthesisThe Journal of Organic Chemistry, 1994
- Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxonePublished by Elsevier ,1992
- Andrimid, a new peptide antibiotic produced by an intracellular bacterial symbiont isolated from a brown planthopperJournal of the American Chemical Society, 1987
- Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsisPublished by Elsevier ,1985